+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical disintegration time of orally disintegrating tablets clinically available in Japan in healthy volunteers



Clinical disintegration time of orally disintegrating tablets clinically available in Japan in healthy volunteers



Biological and Pharmaceutical Bulletin 36(9): 1488-1493



Disintegration time is an important characteristic of orally disintegrating tablets (ODTs), and evaluation of disintegration time is a key step in formulation development, manufacturing, and clinical practice. In this study, we aimed to clarify the clinical disintegration time of ODTs that are currently used clinically, and to evaluate its correlation with the in vitro disintegration time of ODTs which was measured using Tricorptester, a newly developed disintegration testing apparatus. The clinical disintegration time of 17 ODT products was measured in healthy volunteers (n=9-10; age range, 21-28 years). A randomized single-blind trial was performed; each tablet was placed on the tongues of the participants, and it disintegrated in their oral cavities. No significant difference was observed in the clinical disintegration time of each ODT among the 3 groups to which the subjects were randomly assigned. The clinical disintegration time of the 17 ODT products was between 17.6 s and 33.8 s. The in vitro disintegration time of 26 clinically used ODT products measured using Tricorptester ranged between 4.40 s and 30.4 s. A significant positive correlation was observed between in vitro and clinical disintegration times (r=0.79; p<0.001). This study shows that all the tested products, which are clinically available in Japan, showed good disintegration and that the disintegration time varied according to the product. In addition, the in vitro disintegration time of ODTs measured using Tricorptester is a good reflection of the disintegration time in the oral cavity.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052114502

Download citation: RISBibTeXText

PMID: 23995661


Related references

Reduction in the volume of water for ingesting orally disintegrating tablets of solifenacin (Vesicare® OD), and the clinical disintegration time of Vesicare® OD after unit-dose packaging. International Journal of Pharmaceutics 446(1-2): 1-5, 2013

The practical approach to the evaluation of methods used to determine the disintegration time of orally disintegrating tablets (ODTs). Saudi Pharmaceutical Journal 23(4): 437-443, 2016

Evaluation of disintegration properties of orally rapidly disintegrating tablets using a novel disintegration tester. Chemical and Pharmaceutical Bulletin 60(10): 1240-1248, 2013

Bioequivalence trial of orally disintegrating mirtazapine tablets and conventional oral mirtazapine tablets in healthy volunteers. Clinical Drug Investigation 21(6): 437-442, 2001

Development of a new disintegration method for orally disintegrating tablets. Chemical and Pharmaceutical Bulletin 58(7): 885-890, 2010

Studies on disintegration of compressed tablets. I. Effect on disintegration time of the procedure used in incorporating the disintegrating agent. Journal of the American Pharmaceutical Association. American Pharmaceutical Association 46(2): 131-134, 1957

Quantitative evaluation of the disintegration of orally rapid disintegrating tablets by X-ray computed tomography. Chemical and Pharmaceutical Bulletin 60(12): 1502-1507, 2013

Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus. Pharmaceutical Development and Technology 18(2): 464-474, 2013

Evaluation of the palatabilities in 10 different famotidine orally disintegrating tablets by combination of disintegration device and taste sensor. Drug Development and Industrial Pharmacy 41(8): 1387-1392, 2016

Acceptability and disintegration rates of orally disintegrating risperidone tablets in patients with schizophrenia or schizoaffective disorder. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 49(10): 701-703, 2004

Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor. Journal of Pharmacy and Pharmacology 65(9): 1312-1320, 2014

A new modified wetting test and an alternative disintegration test for orally disintegrating tablets. Journal of Pharmaceutical and Biomedical Analysis 120: 391-396, 2016

Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test. Chemical & Pharmaceutical Bulletin 54(8): 1072-1075, 2006

Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera. Chemical & Pharmaceutical Bulletin 50(9): 1181-1186, 2002

Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study. Clinical Therapeutics 31(10): 2242-2248, 2010